Strathespey Crown News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aeon Biopharma, which is currently testing a botulinum toxin complex to treat migraines and other ailments, went public through a special purpose acquisition company, also known as a SPAC, on July 24.

South koreaSouth koreanAllergan botoxDavid moatazediRobert grantStrathespey crownEvolus incAeon biopharmaFortune business insightsNewport beach based alphaeonChief executive david moatazedi